আন্তর্জাতিক রোগীদের জন্য ভারতে স্তন ক্যান্সারের চিকিৎসা

Yes. International patients can share their medical records with a breast cancer specialist in India for an initial medical review before travelling. The specialist may assess biopsy and pathology reports, breast imaging, staging information and previous treatment records and advise whether additional tests or an in-person evaluation are required.

Patients should provide their biopsy or pathology report, mammography and other available breast-imaging reports, relevant scans, blood-test results, previous treatment summaries and current medication details. Where available, **ER, PR and HER2 results** are particularly useful because these biomarkers can influence treatment planning. Indian clinical guidelines identify pathology and ER, PR and HER2 assessment as important components of breast cancer evaluation.

A hospital may recommend a pathology review or additional testing when the existing information is incomplete, outdated or needs confirmation for treatment planning. Depending on the case, the oncology team may recommend additional imaging, pathology review or biomarker testing before finalising treatment.

Depending on the stage and biological characteristics of the cancer, treatment may include breast-conserving surgery, mastectomy, chemotherapy, radiation therapy, hormone therapy, targeted therapy or immunotherapy. Some patients receive systemic treatment before surgery, while others receive additional treatment after surgery. The treatment sequence is individualised according to the patient's diagnosis.

Selected patients may receive targeted therapy or immunotherapy when their cancer characteristics indicate that these treatments are appropriate. For example, HER2 testing can help determine whether HER2-targeted treatment may be relevant, while immunotherapy may be considered in selected breast cancer situations. Treatment eligibility must be determined by the treating oncology team after reviewing the patient's pathology and other clinical information.

Yes. International patients can seek a second medical opinion by providing their pathology reports, imaging, diagnosis, treatment history and other relevant records. A specialist review can help the patient understand the proposed treatment approach and discuss whether other medically appropriate options should be considered before travelling or starting treatment.

The cost varies according to the cancer stage, treatment plan, medicines, surgery, hospitalisation, radiation therapy, targeted therapy and other required investigations. Because breast cancer treatment differs significantly between patients, a personalised estimate should be prepared after specialist review rather than relying on one fixed package or price range. Published Indian studies also show that systemic therapy, radiotherapy, surgery and non-medical expenses can all contribute substantially to the overall treatment cost.

Yes. International patients from these regions can seek breast cancer treatment in India, subject to medical assessment and applicable travel requirements. It is advisable to have the medical records reviewed and the initial treatment pathway discussed before travelling so that the appropriate specialist, hospital and appointments can be coordinated in advance.

The required stay depends on the treatment plan. Patients travelling primarily for surgery may need a shorter stay, while radiation therapy or repeated systemic treatment may require a longer period in India. Some patients may complete surgery or an initial phase of treatment in India and continue certain parts of their treatment or follow-up in their home country when medically appropriate. The treating hospital should provide an individualised timeline.

Before returning home, the patient should obtain the treatment summary, pathology reports, imaging records, medication details and recommended follow-up plan from the treating hospital. Depending on the treatment, ongoing oncology consultations, medicines, laboratory monitoring or imaging may be required. Welltara can help coordinate relevant medical documentation and communication with the treating hospital where applicable.

Welltara can help international patients organise medical records for specialist review, identify suitable hospitals and oncology specialists, coordinate consultations and appointments, and assist with treatment-related travel arrangements such as accommodation and local coordination. The treating oncologist and hospital remain responsible for diagnosis and medical decisions, while Welltara supports the patient's healthcare coordination journey.